%0 Generic
%A Amador A.C.
%A Rodríguez L.J.V.
%A Hernández G.
%A Aguilar D.P.S.
%A Córdoba P.A.B.
%A Muñoz J.L.R.
%A Cely M.D.R.
%A Amador N.F.A.
%8 2022
%@ 23897708
%U http://hdl.handle.net/10818/59965
%X Background: Hepatorenal syndrome is a renal dysfunction that occurs in patients with chronic liver disease such as liver cirrhosis or acute liver disease, characterized by the activation of regulatory mechanisms that lead to a decrease in the glomerular filtration rate. Clinically, hepatorenal syndrome is divided into two types, type 1 and type 2. Type 1 is characterized by a rapid and progressive loss of kidney function while type 2 is characterized by slow progression and a better prognosis. Purpose: To analyze the natural history of the disease presented by patients who develop hepatorenal syndrome. Methodology: A review of the scientific literature of published manuscripts on hepatorenal syndrome was carried out to evaluate the natural history of this pathology. Results: There are no specific clinical findings, however, its clinical manifestations reflect the underlying advanced liver disease, kidney failure, and circulatory abnormalities present. Conclusions: The most appropriate therapeutic option is liver transplantation, but not all patients can receive it, while accessing said management an option is drug treatment with vasoconstrictors and albumin. © 2022, Asociacion Colombiana de Nefrologia e Hipertension Arterial. All rights reserved.
%I Revista Colombiana de Nefrologia
%T Hepatorenal syndrome: Literature review
%T Síndrome hepatorrenal: revisión de la literatura
%R 10.22265/acnef.9.1.539
%~ Intellectum